PAM16
Basic information
Region (hg38): 16:4331549-4355607
Links
Phenotypes
GenCC
Source:
- autosomal recessive spondylometaphyseal dysplasia, Megarbane type (Limited), mode of inheritance: AR
- autosomal recessive spondylometaphyseal dysplasia, Megarbane type (Strong), mode of inheritance: AR
- autosomal recessive spondylometaphyseal dysplasia, Megarbane type (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spondylometaphyseal dysplasia, Megarbane-Dagher-Melki type | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal; Neurologic | 18925669; 24458487; 24786642 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (63 variants)
- not_specified (11 variants)
- Autosomal_recessive_spondylometaphyseal_dysplasia,_Megarbane_type (3 variants)
- PAM16-related_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PAM16 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016069.11. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 12 | ||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 2 | 0 | 24 | 12 | 0 |
Highest pathogenic variant AF is 6.84351e-7
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PAM16 | protein_coding | protein_coding | ENST00000318059 | 5 | 24059 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.235 | 0.735 | 125499 | 0 | 7 | 125506 | 0.0000279 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.511 | 94 | 81.1 | 1.16 | 0.00000540 | 793 |
Missense in Polyphen | 25 | 25.548 | 0.97856 | 284 | ||
Synonymous | 0.0118 | 33 | 33.1 | 0.997 | 0.00000214 | 244 |
Loss of Function | 1.82 | 2 | 7.32 | 0.273 | 3.96e-7 | 81 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000499 | 0.0000462 |
European (Non-Finnish) | 0.0000382 | 0.0000353 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates ATP-dependent protein translocation into the mitochondrial matrix. Inhibits DNAJC19 stimulation of HSPA9/Mortalin ATPase activity. {ECO:0000269|PubMed:20053669}.;
- Disease
- DISEASE: Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type (SMDMDM) [MIM:613320]: An autosomal recessive disease characterized by pre- and postnatal short stature, developmental delay, dysmorphic facial appearance, narrow chest, prominent abdomen, platyspondyly, and short limbs. {ECO:0000269|PubMed:24786642}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Metabolism of proteins;Mitochondrial protein import
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.39
- rvis_percentile_EVS
- 75.87
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.491
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pam16
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- ossification;protein import into mitochondrial matrix;negative regulation of ATPase activity;negative regulation of release of cytochrome c from mitochondria;negative regulation of apoptotic DNA fragmentation
- Cellular component
- PAM complex, Tim23 associated import motor;TIM23 mitochondrial import inner membrane translocase complex;mitochondrial matrix;extrinsic component of mitochondrial inner membrane;protein-containing complex
- Molecular function
- protein binding